Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker

Figure 3

The mRNA levels of ORM2, CD14, BTD and GPX3. Box-plots of log2-transformed average fold changes (log2avFC) of the gene expression levels of BTD, CD14, GPX3 and ORM2 in breast cancer tissues (total n = 1,810) relative to the normal healthy tissues (n = 39). Statistically significant difference between breast cancer and normal tissues were tested by Wilcoxon tests. Breast cancer tissues were categorized into two groups of breast biopsy samples (Biopsy, n = 1,715) and laser capture microdissected samples (LCM, n = 95).

Back to article page